Modulation of CD86 expression in skin dendritic cells does not always correlate with changes in DC motility,

Nicolas Bechetoille1, Aurélie Boher, Amandine Gaydon

  • 1BASF Beauty Care Solutions, 32 rue Saint Jean de Dieu, 69007 Lyon, France. nicolas.bechetoille@basf.com

Insights

CD86 expression on dendritic cells (DCs) is a known activation marker. This study found that DC motility and migration are separate from activation, suggesting compounds may modulate immune responses by down-regulating CD86, not affecting cell movement.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • CD86 is a key activation marker on dendritic cells (DCs).
  • Understanding DC function requires correlating activation markers with functional properties like motility and migration.

Purpose of the Study:

  • To investigate the relationship between CD86 expression and the motility, migration, and allostimulatory capacity of human monocyte-derived skin DCs.
  • To determine if immune response modulation by compounds is linked to CD86 expression or cell motility.

Main Methods:

  • Isolation and characterization of monocyte-derived skin dendritic cells.
  • Assessment of CD86 expression levels via flow cytometry.
  • Analysis of cell motility and migration using live-cell imaging and transwell assays.
  • Evaluation of allostimulatory capacity in mixed lymphocyte reactions.

Main Results:

  • Motility and migratory abilities of DCs can be independent of their activation status indicated by CD86 expression.
  • Down-regulation of CD86 expression by certain compounds correlates with immune response modulation.
  • Observed effects on immune response were not primarily driven by changes in DC motility or migration.

Conclusions:

  • DC activation, motility, and migration are distinct processes.
  • CD86 expression level is a more relevant indicator than motility for certain immune-modulating effects of compounds.
  • Targeting CD86 may be a viable strategy for modulating immune responses.